國家衛生研究院 NHRI:Item 3990099045/11637
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12340/13424 (92%)
造访人次 : 2036773      在线人数 : 439
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于NHRI管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11637


    题名: CD44 promotes migration ability of docetaxel-resistant prostate cancer cells via induction of Hippo-Yap signaling
    作者: Lai, CJ;Chuu, CP;Wang, HD
    贡献者: Institute of Cellular and Systems Medicine
    摘要: Docetaxel-based chemotherapy confers higher five-year survival rate for patients with castration-resistant prostate cancer (CRPC). However, docetaxel-resistant prostate cancers are more malignant related to poor prognosis. We determine the cause of the aggressive phenotype of docetaxel-resistant prostate cancer (PCa). In our study, the docetaxel-resistant CRPC- PC/DX25 cells exhibit higher mobility and express more endogenous CD44. CD44 is a multifunctional protein involved in regulation of drug resistance and cell migration. CD44 has been reported to function as upstream regulator of Yes-associated protein (YAP), a major mediator in Hippo-pathway which is involved in human tumorigenesis. Knockdown of CD44 reduces protein expression of YAP but increases protein level of phospho-YAP S127. Phosphorylation of S127 on YAP suppresses the oncogenic activity of YAP as well as decreases protein expression of CTGF and CYR61, the downstream genes of YAP. CTGF and CYR61 are related to cell migration, cell invasion, and cell adhesion. In conclusion, CD44/YAP pathway may be a potential therapeutic target for docetaxel-resistant CRPCs.
    日期: 2018-12
    關聯: Cancer Science. 2018 Dec;109(Suppl. 2):990.
    Link to: https://doi.org/10.1111/cas.13904
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1347-9032&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000453773604366
    显示于类别:[褚志斌] 會議論文/會議摘要

    文件中的档案:

    档案 大小格式浏览次数
    ISI000453773604366.pdf35KbAdobe PDF265检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈